Blog - Page 2140 of 5730

FridayDec 28, 2018 11:41 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advancing Its Clinical Program, Immunotherapy Seen as Future of Cancer Treatment

Multiple oncology and immunology organizations have identified immunotherapy as the future of cancer treatment BriaCell Therapeutics Corp. is making significant progress in the development of a safe and highly effective immunotherapy solution for advanced breast cancer patients The company is expected to announce new information about the efficacy of its lead product candidate in combination with KEYTRUDA® during the first quarter of 2019 Market forecasts suggest rapid anti-cancer immunotherapy market growth until 2023 For nearly 20 years, researchers have been working on ways to help the immune system better target cancer. New developments in the field are making that possible,…

FridayDec 28, 2018 11:09 am

Net Element, Inc. (NASDAQ: NETE) Keeping Pace with Rising B2B and Consumer Demands for Online Payment Options

NETE platforms offer one-stop omni-channel processing solution with 100-plus payment options E-commerce expected to become largest retail channel in the world by 2021 Consumers quickly migrating toward omni-channel shopping, with up to 80 percent of shoppers planning to buy online during 2018 holiday season Online retail sales jumped 19.1 percent in 2018 over 2017 with U.S. retail sales totaling more than $850 billion Growth in North American market drove Net Element’s net revenue up nine percent Net Element, Inc. (NASDAQ: NETE), a global financial technology and value-added solutions provider that supports electronic payments in an omni-channel environment, is meeting the…

FridayDec 28, 2018 10:53 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Positioned for Opportunity with Federal Legalization of Hemp

Technology and investment company SinglePoint (OTCQB: SING) this morning announced its plans to explore opportunities to produce industrial hemp through joint ventures with leading growers, as well as a potential investment in a development program for cannabidiol (“CBD”) extraction from hemp with passage of the 2108 Farm Bill. New legislation removes the schedule one substance designation for hemp and provides tremendous opportunity for SING and the company’s subsidiary, SingleSeed.com, an ecommerce-based business that sells and supplies industrial-based hemp CBD products. “We are excited for these new opportunities in the hemp market and have been preparing the company to be in…

FridayDec 28, 2018 10:28 am

ChineseInvestors.com, Inc. (CIIX) Appoints Alex Hamilton as CFO of Subsidiary as it Offers CBD-Based Products to Mainland China

Alongside its traditional set of offerings for the Chinese-speaking investment community, ChineseInvestors.com is making strategic moves to capitalize on the burgeoning CBD oil industry Alex Hamilton has been appointed as chief financial officer of subsidiary company CBD Biotechnology, LTD ChineseInvestors.com recognizes the unprecedented industry potential of CBD-based nutrition and wellness products and hopes to offer them to mainland China ChineseInvestors.com, Inc. (OTCQB: CIIX), a premier provider of financial information to Chinese-speaking investors in the United States and China, recently announced the appointment of Alex Hamilton as chief financial officer of CBD Biotechnology, LTD, the company’s wholly owned subsidiary. Hamilton will…

FridayDec 28, 2018 9:54 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Attend Cantech Investment Conference 2019, January 29-30 in Toronto

Summit will highlight 100+ leading technology firms in the international cannabinoid-derived pharmaceuticals space; more than 3,500 investors are expected to attend LXRP is a drug delivery platform innovator with a growing IP portfolio of 10 patents granted and more than 50 patents filed globally LXRP out-licenses its delivery technology, such as its proprietary DehydraTECH; it holds a patent for oral delivery of all cannabinoids Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), a drug delivery platform innovator, will exhibit at the Cantech Investment Conference 2019, taking place on January 29-30 in Toronto, and it will participate in a specialized event where…

FridayDec 28, 2018 9:26 am

QualityStocksNewsBreaks – Icon Exploration Inc. (TSX.V: IEX.H) Director and CEO Exercises Share Purchase Warrants

To update the early warning report issued in August 2017 filed by Icon Exploration (TSX.V: IEX.H) director and CEO Rob Fia, the company recently announced the issuance of 312,500 common shares of the company to Fia at a price of $0.15 each pursuant to the exercise of share purchase warrants. Following the warrant exercise, Fia has ownership and control of 4,613,312 shares of the company. Fia’s resulting interest in Icon is 13.9%, which is a loss of about 2% since August 2017 due to dilution following the completion of a private placement and warrant exercises by other individuals. To view…

ThursdayDec 27, 2018 3:07 pm

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions’ (REFG) ‘Go’ Processing System Offers Safe, Accurate Transactions to the Legalized Marijuana Industry

Medical Cannabis Payment Solutions’ (OTC: REFG) end-to-end payment processing system ‘Go’ offers cannabis dispensaries, merchants and customers a way to safely and accurately make legalized marijuana transactions. A recent article discussing the company reads, “REFG’s Go offers legalized cannabis dispensaries and merchants safety, accuracy and easy online sign-up. It is now available to the entire cannabis market. In addition to creating a cashless environment, Go can handle all payments necessary for a small business retailer, such as payroll and vendor disbursements, accounts payable and any other invoices. … Go is capable of processing cryptocurrency payments. The customer or patient can…

ThursdayDec 27, 2018 2:38 pm

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advancing Clinical Development of its Novel Advanced Breast Cancer Treatment

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), an immuno-oncology focused biotechnology company, is continuing its progression of Bria-IMT for the treatment of advanced breast cancer. An article discussing the company reads, “The Bria-IMT phase I/IIa monotherapy study involved 23 patients who were very heavily pre-treated (a median of four previous systemic therapy regiments per patient). The treatment with Bria-IMT was well-tolerated, with minor local irritation at the injection site being reported as the most common adverse effect. … More importantly, Bria-IMT contributed to tumor shrinkage in three of the patients. The top respondent previously received seven rounds of chemotherapy and had…

ThursdayDec 27, 2018 2:05 pm

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Fast-tracks Exploration at its Flagship Project

Pure-play cobalt company First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) is accelerating development of its Iron Creek Cobalt Project in Idaho, with plans to complete an updated resource estimate early next year. An article discussing the company reads, “Drilling at the Idaho site has identified an expanding number of areas with commercial potential, and the company is working to complete an updated resource estimate by early 2019. The company announced its latest drilling results shortly before Thanksgiving (http://ibn.fm/dVvMk), with CEO Trent Mell’s evaluation that the results “confirm the continuity and consistency of mineralization predicted by our geological model and…

ThursdayDec 27, 2018 1:23 pm

QualityStocksNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Co-Founder Showcased in Globally-viewed Documentary

Leading omni-direct lifestyle company Youngevity International’s (NASDAQ: YGYI) co-founder Dr. Joel Wallach was recently featured in a documentary that highlights his impactful career of spreading health and wellness awareness worldwide. A recent article discussing the film reads, “A recent documentary on the Youngevity founder has been released by Carpe Diem Media. It is titled “The Audacity of Health: The Dr. Joel Wallach Story” and has already garnered a global following thanks to social media. The documentary traces the evolution of Wallach’s quest to spread health and wellness from the 1960s through his four decades of work in the industry. Most…

Site Search

Company Search